1. Home
  2. ACIW vs BLLN Comparison

ACIW vs BLLN Comparison

Compare ACIW & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACI Worldwide Inc.

ACIW

ACI Worldwide Inc.

HOLD

Current Price

$41.87

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$83.72

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACIW
BLLN
Founded
1975
2016
Country
United States
United States
Employees
N/A
713
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ACIW
BLLN
Price
$41.87
$83.72
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$62.50
$126.71
AVG Volume (30 Days)
685.8K
380.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
13.09
N/A
EPS
2.16
N/A
Revenue
$1,009,780,000.00
N/A
Revenue This Year
$9.67
$46.29
Revenue Next Year
$7.41
$30.14
P/E Ratio
$20.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.05
$61.96
52 Week High
$55.45
$138.70

Technical Indicators

Market Signals
Indicator
ACIW
BLLN
Relative Strength Index (RSI) 49.96 53.21
Support Level $38.70 $79.33
Resistance Level $43.01 $98.48
Average True Range (ATR) 1.34 6.77
MACD 0.23 0.40
Stochastic Oscillator 39.16 41.88

Price Performance

Historical Comparison
ACIW
BLLN

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets, and installs a portfolio of software products focused on facilitating electronic payments. The firm's products are sold and supported directly and through distribution networks covering three geographic regions - the Americas, EMEA, and Asia Pacific. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but the majority of the revenue is generated in the United States and EMEA regions. The company's operating segment includes Payment Software and Biller. The company generates the majority of its revenue from the Payment Software segment.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: